Deutsch
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
carnitine/entzündung
Der Link wird in der Zwischenablage gespeichert
Seite 1 von 16 Ergebnisse
Use of alkanoyl L-carnitines for the therapeutical treatment of chronic inflammatory bowel disease
Nur registrierte Benutzer können Artikel übersetzen
Einloggen Anmelden
The present invention relates to a new therapeutic use of the lower alkanoyl L-carnitines and their pharmacologically acceptable salts to produce pharmaceutical compositions for the treatment of chronic inflammatory bowel diseases, and, in particular, ulcerative colitis.
The present invention also
Use of alkanoyl L-carnitines for the therapeutical treatment of chronic inflammatory bowel diseases
Nur registrierte Benutzer können Artikel übersetzen
Einloggen Anmelden
The present invention relates to a new therapeutic use of the lower alkanoyl L-carnitines and their pharmacologically acceptable salts to produce pharmaceutical compositions for the treatment of chronic inflammatory bowel diseases, and, in particular, ulcerative colitis.
The present invention also
Carnitine and inositol phosphate-containing composition useful as dietary supplement or drug
Nur registrierte Benutzer können Artikel übersetzen
Einloggen Anmelden
This application is a 371 of PCT/IT00/00158 filed Apr. 19, 2000.
The present invention relates to a composition for the prevention and/or treatment of cardiovascular and neurocerebral disorders, various tissue anoxic forms, energetic muscular deficits, inflammatory type-abnormalities, blood
Methods for the diagnosis, control and prophylaxis of inflammation and mitigation of inflammatory conditions in canines
Nur registrierte Benutzer können Artikel übersetzen
Einloggen Anmelden
FIELD OF THE INVENTION
The invention relates to methods of diagnosis, control and prophylaxis of inflammation and mitigation of inflammatory conditions, particularly arthritis and joint pain, in canines, comprising measuring inflammatory biomarkers wherein elevated levels of the biomarkers in blood
Complexes of hyaluronic acid/carnitines and pharmaceutical and cosmetic compositions
Nur registrierte Benutzer können Artikel übersetzen
Einloggen Anmelden
This application is a 371 of PCT/IT99/00364 filed Nov. 11, 1999.
The present invention relates to complexes of hyaluronic acid and "carnitines", the latter herein meaning both carnitine as it is and, more specifically, its acyl derivatives with straight or branched chain aliphatic carboxylic acids,
Carnitine conjugates of adamantanamines derivatives as dual prodrugs for various uses
Nur registrierte Benutzer können Artikel übersetzen
Einloggen Anmelden
FIELD OF THE INVENTION
Amantadine (1-aminoadamantane) is an antiviral agent in clinical use. [See for example, Aldrich, P. E. et al., J. Med. Chem. 14, 535-543 (1972).] Memantine (3,5-dimethyl-1-adamantanamine) and its pharmaceutically acceptable salts are approved for the treatment of moderate to
Carnitine conjugates of adamantanamines and neramexane derivatives as dual prodrugs for various uses
Nur registrierte Benutzer können Artikel übersetzen
Einloggen Anmelden
FIELD OF THE INVENTION
Amantadine (1-aminoadamantane) is an antiviral agent in clinical use. [See for example, Aldrich, P. E. et al., J. Med. Chem. 14, 535-543 (1972).] Memantine (3,5-dimethyl-1-adamantanamine) and its pharmaceutically acceptable salts are approved for the treatment of moderate to
Combination composition in the form of nutritional supplement or pharmaceutical composition for the prevention and therapeutical treatment of degenerative or inflammatory articular disorders
Nur registrierte Benutzer können Artikel übersetzen
Einloggen Anmelden
The present invention relates to a composition suitable both for the prevention of articular disorders and for the therapeutic treatment of articular diseases. Accordingly, the composition may take the form and exert the activity of a food or dietary supplement or of an actual medicament in the
Method of using .beta.-hydroxy-.beta.-methylbutyrate for the treatment of disease conditions
Nur registrierte Benutzer können Artikel übersetzen
Einloggen Anmelden
The present invention relates to methods for the prevention and treatment of chronic inflammatory diseases, cancer, and involuntary weight loss. In the practice of the present invention patients are enterally administered HMB alone or alternatively in combination with eicosapentaenoic (20:5
Method of using beta-hydroxy-beta-methylbutyrate for treating disease-associated wasting
Nur registrierte Benutzer können Artikel übersetzen
Einloggen Anmelden
BACKGROUND
Undesired weight loss, particularly lean mass loss is a relatively common occurrence in critical illness, and has a significant impact on morbidity and mortality. This is particularly true in cancer patients, where such mass losses can become treatment-limiting, and thus impact overall
HMB uses thereof
Nur registrierte Benutzer können Artikel übersetzen
Einloggen Anmelden
The present invention relates to methods for the prevention and treatment of chronic inflammatory diseases, cancer, and involuntary weight loss. In the practice of the present invention patients are enterally administered HMB alone or alternatively in combination with eicosapentaenoic (20:5
Method of using beta-hydroxy-beta-methylbutyrate for reducing tumor growth rate
Nur registrierte Benutzer können Artikel übersetzen
Einloggen Anmelden
The present invention relates to methods for the prevention and treatment of chronic inflammatory diseases, cancer, and involuntary weight loss. In the practice of the present invention patients are enterally administered HMB alone or alternatively in combination with eicosapentaenoic (20:5
Method of using beta-hydroxy-beta-methylbutyrate and fatty acids for treating disease-associated wasting
Nur registrierte Benutzer können Artikel übersetzen
Einloggen Anmelden
BACKGROUND
Undesired weight loss, particularly lean mass loss is a relatively common occurrence in critical illness, and has a significant impact on morbidity and mortality. This is particularly true in cancer patients, where such mass losses can become treatment-limiting, and thus impact overall
Acetylsalicylic acid salts
Nur registrierte Benutzer können Artikel übersetzen
Einloggen Anmelden
FIELD OF INVENTION
The present invention relates in general to acetylsalicylic acid salts, and in particular to a new and useful water soluble acetylsalicylic acid salts and the method of making the same. Acetylsalicylic acid is a most widely used drug, known chiefly for its analgesic properties.
Equine nutritional supplement
Nur registrierte Benutzer können Artikel übersetzen
Einloggen Anmelden
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates generally to nutritional supplements for humans, animals, and, more particularly, to nutritional supplements for equines, and even more particularly for racehorses.
2. Description of the Prior Art
The training of
Die vollständigste Datenbank für Heilkräuter, die von der Wissenschaft unterstützt wird
- Arbeitet in 55 Sprachen
- Von der Wissenschaft unterstützte Kräuterkuren
- Kräutererkennung durch Bild
- Interaktive GPS-Karte - Kräuter vor Ort markieren (in Kürze)
- Lesen Sie wissenschaftliche Veröffentlichungen zu Ihrer Suche
- Suchen Sie nach Heilkräutern nach ihrer Wirkung
- Organisieren Sie Ihre Interessen und bleiben Sie über Neuigkeiten, klinische Studien und Patente auf dem Laufenden
Geben Sie ein Symptom oder eine Krankheit ein und lesen Sie über Kräuter, die helfen könnten, geben Sie ein Kraut ein und sehen Sie Krankheiten und Symptome, gegen die es angewendet wird.
* Alle Informationen basieren auf veröffentlichten wissenschaftlichen Forschungsergebnissen
